Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Cancer Cell
|
December 13, 2017
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Xueqian Gong, Lacey M Litchfield, Yue Webster, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease
Cynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Cancer Discovery
|
October 31, 2018
Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene
Xueqian Gong, Jian Du, Stephen H Parsons, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Molecular Cancer Therapeutics
|
September 19, 2019
Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
Jian Du, Lei Yan, Raquel Torres, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Cancer Cell
|
December 13, 2017
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Xueqian Gong, Lacey M Litchfield, Yue Webster, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease
Cynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Journal of Medicinal Chemistry
|
April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Cancer Discovery
|
October 31, 2018
Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene
Xueqian Gong, Jian Du, Stephen H Parsons, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models
Cynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Molecular Cancer Therapeutics
|
September 19, 2019
Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
Jian Du, Lei Yan, Raquel Torres, et al.
Page
of 5